These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 9238169

  • 1. [Tribulations of the p16/MTS1/CDKN2 tumor gene suppressor: a continuing saga].
    Larsen CJ.
    Bull Cancer; 1997 Apr; 84(4):427-30. PubMed ID: 9238169
    [Abstract] [Full Text] [Related]

  • 2. Alterations of the putative tumor suppressor gene p16/MTS1 in human hematological malignancies.
    Duro D, Flexor MA, Bernard O, d'Agay MF, Berger R, Larsen CJ.
    C R Acad Sci III; 1994 Oct; 317(10):913-9. PubMed ID: 7882134
    [Abstract] [Full Text] [Related]

  • 3. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers.
    Herman JG, Merlo A, Mao L, Lapidus RG, Issa JP, Davidson NE, Sidransky D, Baylin SB.
    Cancer Res; 1995 Oct 15; 55(20):4525-30. PubMed ID: 7553621
    [Abstract] [Full Text] [Related]

  • 4. Methylation of the multi tumor suppressor gene-2 (MTS2, CDKN1, p15INK4B) in childhood acute lymphoblastic leukemia.
    Iravani M, Dhat R, Price CM.
    Oncogene; 1997 Nov 20; 15(21):2609-14. PubMed ID: 9399648
    [Abstract] [Full Text] [Related]

  • 5. Mechanisms of p16INK4A inactivation in non small-cell lung cancers.
    Gazzeri S, Gouyer V, Vour'ch C, Brambilla C, Brambilla E.
    Oncogene; 1998 Jan 29; 16(4):497-504. PubMed ID: 9484839
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Frequent and selective methylation of p15 and deletion of both p15 and p16 in T-cell acute lymphoblastic leukemia.
    Batova A, Diccianni MB, Yu JC, Nobori T, Link MP, Pullen J, Yu AL.
    Cancer Res; 1997 Mar 01; 57(5):832-6. PubMed ID: 9041181
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The prognostic significance of p16INK4a/p14ARF and p15INK4b deletions in adult acute lymphoblastic leukemia.
    Faderl S, Kantarjian HM, Manshouri T, Chan CY, Pierce S, Hays KJ, Cortes J, Thomas D, Estrov Z, Albitar M.
    Clin Cancer Res; 1999 Jul 01; 5(7):1855-61. PubMed ID: 10430092
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The human protein p19ARF is not detected in hemopoietic human cell lines that abundantly express the alternative beta transcript of the p16INK4a/MTS1 gene.
    Della Valle V, Duro D, Bernard O, Larsen CJ.
    Oncogene; 1997 Nov 13; 15(20):2475-81. PubMed ID: 9395243
    [Abstract] [Full Text] [Related]

  • 17. Inactivation of the P16INK4/MTS1 gene by a chromosome translocation t(9;14)(p21-22;q11) in an acute lymphoblastic leukemia of B-cell type.
    Duro D, Bernard O, Della Valle V, Leblanc T, Berger R, Larsen CJ.
    Cancer Res; 1996 Feb 15; 56(4):848-54. PubMed ID: 8631023
    [Abstract] [Full Text] [Related]

  • 18. Methylation status of cyclin-dependent kinase inhibitor genes within the transforming growth factor beta pathway in human T-cell lymphoblastic lymphoma/leukemia.
    Scott SA, Kimura T, Dong WF, Ichinohasama R, Bergen S, Kerviche A, Sheridan D, DeCoteau JF.
    Leuk Res; 2004 Dec 15; 28(12):1293-301. PubMed ID: 15475071
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Alternative protein p19ARF: a genuine tumor suppressor gene].
    Larsen CJ.
    Bull Cancer; 1998 Apr 15; 85(4):304-6. PubMed ID: 9752293
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.